Department of Health Sciences, University of Piemonte Orientale, Novara, Italy; Department of Surgery, University Maggiore Hospital della Carità, Novara, Italy.
Department of Surgical Science, University of Cagliari, Cagliari, Italy.
HPB (Oxford). 2024 Aug;26(8):1022-1032. doi: 10.1016/j.hpb.2024.05.001. Epub 2024 May 13.
There is lack of data on the association between socioeconomic factors, guidelines compliance and clinical outcomes among patients with acute biliary pancreatitis (ABP).
Post-hoc analysis of the international MANCTRA-1 registry evaluating the impact of regional disparities as indicated by the Human Development Index (HDI), and guideline compliance on ABP clinical outcomes. Multivariable logistic regression models were employed to identify prognostic factors associated with mortality and readmission.
Among 5313 individuals from 151 centres across 42 countries marked disparities in comorbid conditions, ABP severity, and medical procedure usage were observed. Patients from lower HDI countries had higher guideline non-compliance (p < 0.001) and mortality (5.0% vs. 3.2%, p = 0.019) in comparison with very high HDI countries. On adjusted analysis, ASA score (OR 1.810, p = 0.037), severe ABP (OR 2.735, p < 0.001), infected necrosis (OR 2.225, p = 0.006), organ failure (OR 4.511, p = 0.001) and guideline non-compliance (OR 2.554, p = 0.002 and OR 2.178, p = 0.015) were associated with increased mortality. HDI was a critical socio-economic factor affecting both mortality (OR 2.452, p = 0.007) and readmission (OR 1.542, p = 0.046).
These data highlight the importance of collaborative research to characterise challenges and disparities in global ABP management. Less developed regions with lower HDI scores showed lower adherence to clinical guidelines and higher rates of mortality and recurrence.
急性胆源性胰腺炎(ABP)患者的社会经济因素、指南依从性与临床结局之间的关联数据匮乏。
对评估地域差异(以人类发展指数(HDI)表示)以及指南依从性对 ABP 临床结局影响的国际 MANCTRA-1 注册研究进行事后分析。采用多变量逻辑回归模型确定与死亡率和再入院相关的预后因素。
在来自 42 个国家 151 个中心的 5313 名患者中,观察到合并症、ABP 严重程度和医疗程序使用方面存在明显差异。与 HDI 极高的国家相比,来自 HDI 较低国家的患者指南依从性较差(p<0.001),死亡率较高(5.0% vs. 3.2%,p=0.019)。在调整分析中,ASA 评分(OR 1.810,p=0.037)、重度 ABP(OR 2.735,p<0.001)、感染性坏死(OR 2.225,p=0.006)、器官衰竭(OR 4.511,p=0.001)和指南不依从(OR 2.554,p=0.002 和 OR 2.178,p=0.015)与死亡率增加相关。HDI 是一个关键的社会经济因素,影响死亡率(OR 2.452,p=0.007)和再入院率(OR 1.542,p=0.046)。
这些数据强调了开展协作研究以明确全球 ABP 管理面临的挑战和差异的重要性。HDI 评分较低的欠发达地区对临床指南的依从性较低,死亡率和复发率较高。